This is a medicine called Carbamazepine. It's often used to help control seizures (fits). It can also help manage certain types of mood swings in bipolar disorder and sometimes ease nerve pain.
Every report comes from a Lived member, sent anonymously.
Have you tried Tegretol (Carbamazepine) for Bipolar Disorder?
Carbamazepine, sold under brand names including Tegretol, is an anticonvulsant (antiseizure) medicine. It is used to prevent focal seizures, which start in one part of the brain (including the type once called psychomotor or temporal lobe seizures), generalized tonic-clonic seizures (the convulsive type once called grand mal), and mixtures of the two. It does not control absence seizures, the brief staring spells once called petit mal, and in some people whose mixed seizure pattern includes them it can make convulsions more frequent. Carbamazepine is also approved to treat trigeminal neuralgia, a condition that causes attacks of severe facial nerve pain. A European neurology guideline recommends it, along with the related medicine oxcarbazepine, as a first-choice drug for long-term control. It is not an ordinary pain reliever and is not meant for everyday aches. One extended-release brand, Equetro, is additionally approved for acute manic or mixed episodes of bipolar I disorder. Mania is a period of abnormally elevated, excited or irritable mood; a mixed episode combines symptoms of mania and depression. Tegretol-XR and Carbatrol are other extended-release versions.
Seizures happen when nerve cells in the brain fire in an abnormal, excessive burst of electrical activity. Carbamazepine reduces this abnormal activity, which makes seizures less likely to start. In trigeminal neuralgia, it changes the way the body senses pain, which can reduce the sudden attacks. The precise way it produces these effects, including its benefit in mania, is still not fully understood. The liver breaks carbamazepine down, and the drug speeds up several of the liver enzymes that do this work. That has two practical consequences: its own blood level tends to fall over the first several weeks on a steady dose, and it changes the levels of many other medicines.
Carbamazepine comes as regular tablets, a liquid suspension, extended-release tablets (Tegretol-XR) and extended-release capsules (Carbatrol, Equetro). Regular tablets and the liquid are taken two to four times a day, and Tegretol labeling advises taking them with meals. Extended-release forms are taken twice a day. The prescriber starts with a low dose and raises it gradually, usually week by week, to limit side effects, then aims for the lowest dose that works. Extended-release tablets must be swallowed whole, never crushed or chewed, and a chipped or cracked tablet should not be taken. The empty tablet shell can sometimes be seen in the stool, which is expected. Extended-release capsules can be swallowed whole or opened and sprinkled on a spoonful of soft food such as applesauce, but the beads should not be crushed or chewed. The liquid should not be mixed with or taken at the same time as other liquid medicines. When switching between forms, the total daily amount usually stays the same but the schedule changes, so switches should go through the prescriber. Blood tests that measure the carbamazepine level help guide the dose. Do not stop taking it suddenly. In people with epilepsy, stopping abruptly can bring on seizures, or even status epilepticus, a prolonged and life-threatening seizure. Any reduction is done gradually.
Dizziness, drowsiness, unsteadiness, nausea and vomiting are the most common side effects, especially early in treatment, which is one reason the dose is raised slowly. Blurred or double vision and clumsiness can also occur. Alcohol can add to the drowsiness, and until you know how carbamazepine affects you, take care with driving or other hazardous tasks. A new rash needs prompt attention. Carbamazepine can cause rare but serious, sometimes fatal skin reactions called Stevens-Johnson syndrome and toxic epidermal necrolysis, in which the skin blisters and peels; most begin within the first few months. A related reaction called DRESS (drug reaction with eosinophilia and systemic symptoms) can cause fever, swollen glands and facial swelling and can damage the liver, kidneys or other organs, sometimes before any rash appears. Contact the prescriber right away about a rash, fever with swollen glands, sore throat, mouth sores, easy bruising or yellowing of the skin or eyes, since these can also signal rare problems with the blood cells or liver. Swelling of the face, lips, tongue or throat, or difficulty swallowing or breathing, can be a severe allergic reaction and needs emergency care. Carbamazepine can lower the sodium level in the blood, particularly in older adults and people taking diuretics (water pills). Headache, confusion, trouble concentrating, weakness, unsteadiness or more frequent seizures can be signs and should be reported. Like all antiseizure medicines, its labeling warns that it can increase suicidal thoughts or behavior in a small number of people. New or worsening depression, unusual changes in mood or behavior, or thoughts of self-harm should be reported promptly.
Carbamazepine carries a boxed warning, the most prominent warning the US Food and Drug Administration requires, about two risks. The first is the serious skin reactions described above. They are far more likely in people who carry an inherited variant of an immune-system gene, called HLA-B*1502, which is found almost only in people with ancestry from broad areas of Asia, including South Asia. People with this ancestry should have a genetic test before starting, and carriers generally should not take carbamazepine unless the benefit clearly outweighs the risk. A negative test lowers the risk but does not remove it. The second is rare bone marrow failure: aplastic anemia, in which the marrow stops making enough blood cells, and agranulocytosis, a severe loss of infection-fighting white blood cells. A blood count is taken before treatment as a baseline, and liver tests are checked before and during treatment. Carbamazepine interacts with a long list of medicines, in both directions. It speeds the breakdown of many drugs, so they may work less well. Hormonal birth control, including pills and the levonorgestrel implant, can fail, so a backup or non-hormonal method is worth discussing. It should generally not be combined with the newer blood thinners apixaban (Eliquis), rivaroxaban (Xarelto), dabigatran or edoxaban, whose levels can fall too low to prevent clots. It also lowers levels of warfarin and of some antidepressants, antipsychotics and other antiseizure medicines. In the other direction, some antibiotics (such as erythromycin and clarithromycin), antifungal medicines, the heart medicines diltiazem and verapamil, and grapefruit juice can push carbamazepine to toxic levels. It should not be taken with monoamine oxidase (MAO) inhibitors, an older type of antidepressant, or with the antidepressant nefazodone. Tell every prescriber and pharmacist that you take carbamazepine, including before starting or stopping any medicine or supplement. About a third of people who have had an allergic reaction to carbamazepine also react to the related medicine oxcarbazepine (Trileptal), and a past reaction to other antiseizure medicines such as phenytoin calls for caution. Carbamazepine is not used in people with previous bone marrow suppression or sensitivity to tricyclic antidepressants, and it is avoided in hepatic porphyria, a rare inherited disorder that it can trigger. Taken during pregnancy, carbamazepine can cause birth defects, including spina bifida, a defect of the developing spine and spinal cord. Anyone who could become pregnant should plan with the prescriber before and during treatment. People with epilepsy who become pregnant should not stop it suddenly, because severe or uncontrolled seizures are also dangerous to both parent and baby. Carbamazepine passes into breast milk, so breastfeeding should be discussed as well.
Side effects are usually most noticeable while the dose is being built up and often ease with time. Because carbamazepine speeds its own breakdown, its blood level tends to drift down over the first three to five weeks on a steady dose, so the dose is often adjusted during this period. Blood levels may also be checked if seizures change, side effects appear, or other medicines are started or stopped. In adults the usual range is 4 to 12 micrograms per milliliter, but the right level is judged by seizure control and side effects rather than by the number alone. For epilepsy, carbamazepine is usually a long-term treatment. The aim is fewer or no seizures with side effects a person can live with. If seizures continue or side effects become a problem, the dose may change, or another medicine may be added or substituted. For trigeminal neuralgia, labeling advises trying to lower the dose, or even stop, at least every three months to find the smallest amount that keeps pain controlled. If medicine does not control the pain or is poorly tolerated, surgery is an option for some people. Follow-up usually includes periodic blood counts and liver tests, and labeling also recommends periodic eye and urine checks. The warning signs described under side effects still matter after months of treatment, not only at the start.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Tegretol (Carbamazepine), what you've noticed, or ask the community a question.